RESUMEN
PURPOSE: Magnetoliposomes (MLs) have shown great potential as magnetic resonance imaging contrast agents and as delivery vehicles for cancer therapy. Targeting the MLs towards the tumor cells or neovascularization could ensure delivery of drugs at the tumor site. In this study, we evaluated the potential of MLs targeting the αvß3 integrin overexpressed on tumor neovascularization and different tumor cell types, including glioma and ovarian cancer. METHODS: MLs functionalized with a Texas Red fluorophore (anionic MLs), and with the fluorophore and the cyclic Arginine-Glycine-Aspartate (cRGD; cRGD-MLs) targeting the αvß3 integrin, were produced in-house. Swiss nude mice were subcutaneously injected with 107 human ovarian cancer SKOV-3 cells. Tumors were allowed to grow for 3 weeks before injection of anionic or cRGD-MLs. Biodistribution of MLs was followed up with a 7T preclinical magnetic resonance imaging (MRI) scanner and fluorescence imaging (FLI) right after injection, 2h, 4h, 24h and 48h post injection. Ex vivo intratumoral ML uptake was confirmed using FLI, electron paramagnetic resonance spectroscopy (EPR) and histology at different time points post injection. RESULTS: In vivo, we visualized a higher uptake of cRGD-MLs in SKOV-3 xenografts compared to control, anionic MLs with both MRI and FLI. Highest ML uptake was seen after 4h using MRI, but only after 24h using FLI indicating the lower sensitivity of this technique. Furthermore, ex vivo EPR and FLI confirmed the highest tumoral ML uptake at 4 h. Last, a Perl's stain supported the presence of our iron-based particles in SKOV-3 xenografts. CONCLUSION: Uptake of cRGD-MLs can be visualized using both MRI and FLI, even though the latter was less sensitive due to lower depth penetration. Furthermore, our results indicate that cRGD-MLs can be used to target SKOV-3 xenograft in Swiss nude mice. Therefore, the further development of this particles into theranostics would be of interest.
Asunto(s)
Fenómenos Magnéticos , Neoplasias/irrigación sanguínea , Neovascularización Patológica/terapia , Oligopéptidos/química , Animales , Línea Celular Tumoral , Dispersión Dinámica de Luz , Femenino , Humanos , Integrina alfaVbeta3/metabolismo , Liposomas , Imagen por Resonancia Magnética , Ratones Desnudos , Neoplasias/diagnóstico por imagen , Neoplasias/patología , Neovascularización Patológica/patología , Imagen Óptica , Ensayos Antitumor por Modelo de XenoinjertoRESUMEN
Magnetoliposomes (MLs) were synthesized and tested for longitudinal monitoring of transplanted pancreatic islets using magnetic resonance imaging (MRI) in rat models. The rat insulinoma cell line INS-1E and isolated pancreatic islets from outbred and inbred rats were used to optimize labeling conditions in vitro. Strong MRI contrast was generated by islets exposed to 50 µg Fe/ml for 24 hours without any increased cell death, loss of function or other signs of toxicity. In vivo experiments showed that pancreatic islets (50-1000 units) labeled with MLs were detectable for up to 6 weeks post-transplantation in the kidney subcapsular space. Islets were also monitored for two weeks following transplantation through the portal vein of the liver. Hereby, islets labeled with MLs and transplanted under the left kidney capsule were able to correct hyperglycemia and had stable MRI signals until nephrectomy. Interestingly, in vivo MRI of streptozotocin induced diabetic rats transplanted with allogeneic islets demonstrated loss of MRI contrast between 7-16 days, indicative of loss of islet structure. MLs used in this study were not only beneficial for monitoring the location of transplanted islets in vivo with high sensitivity but also reported on islet integrity and hereby indirectly on islet function and rejection.
Asunto(s)
Medios de Contraste/metabolismo , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Experimental/patología , Islotes Pancreáticos/metabolismo , Islotes Pancreáticos/patología , Nanopartículas de Magnetita/administración & dosificación , Animales , Células Cultivadas , Diabetes Mellitus Experimental/inducido químicamente , Hiperglucemia/metabolismo , Hiperglucemia/patología , Insulina/metabolismo , Trasplante de Islotes Pancreáticos/métodos , Hígado/metabolismo , Hígado/patología , Estudios Longitudinales , Imagen por Resonancia Magnética/métodos , Vena Porta/metabolismo , Vena Porta/patología , Ratas , Ratas Endogámicas Lew , Ratas Wistar , Estreptozocina/farmacologíaRESUMEN
Pancreatic islets (PIs) transplantation is an alternative approach for the treatment of severe forms of type 1 diabetes (T1D). To monitor the success of transplantation, it is desirable to follow the location of engrafted PIs non-invasively. In vivo magnetic resonance imaging (MRI) of transplanted PIs is a feasible cell tracking method; however, this requires labeling with a suitable contrast agent prior to transplantation. We have tested the feasibility of cationic magnetoliposomes (MLs), compared to commercial contrast agents (Endorem and Resovist), by labeling insulinoma cells and freshly isolated rat PIs. It was possible to incorporate Magnetic Ressonance (MR)-detectable amounts of MLs in a shorter time (4 h) when compared to Endorem and Resovist. MLs did not show negative effects on the PIs' viability and functional parameters in vitro. Labeled islets were transplanted in the renal sub-capsular region of healthy mice. Hypointense contrast in MR images due to the labeled PIs was detected in vivo upon transplantation, while MR detection of PIs labeled with Endorem and Resovist was only possible after the addition of transfection agents. These findings indicate that MLs are suitable to image PIs, without affecting their function, which is promising for future longitudinal pre-clinical and clinical studies involving the assessment of PI transplantation.
RESUMEN
The aim of this study was to assess a novel lactose functionalized magnetoliposomes (MLs) as an MR contrast agent to target hepatocytes as well as to evaluate the targeting ability of MLs for in vivo applications. In the present work, 17 nm sized iron oxide cores functionalized with anionic MLs bearing lactose moieties were used for targeting the asialoglycoprotein receptor (ASGP-r), which is highly expressed in hepatocytes. Non-functionalized anionic MLs were tested as negative controls. The size distribution of lactose and anionic MLs was determined by transmission electron microscopy (TEM) and dynamic light scattering (DLS). After intravenous administration of both MLs, contrast enhancement in the liver was observed by magnetic resonance imaging (MRI). Label retention was monitored non-invasively by MRI and validated with Prussian blue staining and TEM for up to eight days post MLs administration. Although the MRI signal intensity did not show significant differences between functionalized and non-functionalized particles, iron-specific Prussian blue staining and TEM analysis confirmed the uptake of lactose MLs mainly in hepatocytes. In contrast, non-functionalized anionic MLs were mainly taken up by Kupffer and sinusoidal cells. Target specificity was further confirmed by high-resolution MR imaging of phantoms containing isolated hepatocytes, Kupffer cell (KCs) and hepatic stellate cells (HSCs) fractions. Hypointense signal was observed for hepatocytes isolated from animals which received lactose MLs but not from animals which received anionic MLs. These data demonstrate that galactose-functionalized MLs can be used as a hepatocyte targeting MR contrast agent to potentially aid in the diagnosis of hepatic diseases if the non-specific uptake by KCs is taken into account.
Asunto(s)
Receptor de Asialoglicoproteína/análisis , Medios de Contraste , Hepatocitos/citología , Lactosa , Liposomas , Imagen por Resonancia Magnética/métodos , Animales , Aniones/química , Células Cultivadas , Medios de Contraste/química , Compuestos Férricos/química , Hepatocitos/patología , Hepatocitos/ultraestructura , Lactosa/química , Liposomas/química , Hígado/citología , Hígado/patología , Hígado/ultraestructura , Hepatopatías/diagnóstico , Masculino , RatonesRESUMEN
The need to track and evaluate the fate of transplanted cells is an important issue in regenerative medicine. In order to accomplish this, pre-labelling cells with magnetic resonance imaging (MRI) contrast agents is a well-established method. Uptake of MRI contrast agents by non-phagocytic stem cells, and factors such as cell homeostasis or the adverse effects of contrast agents on cell biology have been extensively studied, but in the context of nanoparticle (NP)-specific parameters. Here, we have studied three different types of NPs (Endorem®, magnetoliposomes [MLs], and citrate coated C-200) to label relatively larger, mesenchymal stem cells (MSCs) and, much smaller yet faster proliferating, multipotent adult progenitor cells (MAPCs). Both cell types are similar, as they are isolated from bone marrow and have substantial regenerative potential, which make them interesting candidates for comparative experiments. Using NPs with different surface coatings and sizes, we found that differences in the proliferative and morphological characteristics of the cells used in the study are mainly responsible for the fate of endocytosed iron, intracellular iron concentration, and cytotoxic responses. The quantitative analysis, using high-resolution electron microscopy images, demonstrated a strong relationship between cell volume/surface, uptake, and cytotoxicity. Interestingly, uptake and toxicity trends are reversed if intracellular concentrations, and not amounts, are considered. This indicates that more attention should be paid to cellular parameters such as cell size and proliferation rate in comparative cell-labeling studies.
Asunto(s)
Medios de Contraste/farmacocinética , Imagen por Resonancia Magnética/métodos , Células Madre/citología , Células Madre/metabolismo , Animales , Proliferación Celular/efectos de los fármacos , Medios de Contraste/química , Medios de Contraste/farmacología , Humanos , Nanopartículas de Magnetita/química , Ratones , Ratas , Coloración y Etiquetado , Células Madre/químicaRESUMEN
This work deals with the production and characterization of water-compatible, iron oxide based nanoparticles covered with functional poly(ethylene glycol) (PEG)-biotin surface groups (SPIO-PEG-biotin). Synthesis of the functionalized colloids occurred by incubating the oleate coated particles used as precursor magnetic fluid with anionic liposomes containing 14 mol% of a phospholipid-PEG-biotin conjugate. The latter was prepared by coupling dimyristoylphosphatidylethanolamine (DC(14:0)PE) to activated α-biotinylamido-ω -N-hydroxy-succinimidcarbonyl-PEG (NHS-PEG-biotin). Physical characterization of the oleate and PEG-biotin iron oxide nanocolloids revealed that they appear as colloidal stable clusters with a hydrodynamic diameter of 160 nm and zeta potentials of - 39 mV (oleate coated particles) and - 14 mV (PEG-biotin covered particles), respectively, as measured by light scattering techniques. Superconducting quantum interference device (SQUID) measurements revealed specific saturation magnetizations of 62-73 emu g(-1) Fe(3)O(4) and no hysteresis was observed at 300 K. MR relaxometry at 3 T revealed very high r(2) relaxivities and moderately high r(1) values. Thus, both nanocolloids can be classified as small, superparamagnetic, negative MR contrast agents. The capacity to functionalize the particles was illustrated by binding streptavidin alkaline phosphatase (SAP). It was found, however, that these complexes become highly aggregated after capturing them on the magnetic filter device during high-gradient magnetophoresis, thereby reducing the accessibility of the SAP.
Asunto(s)
Fosfatasa Alcalina/química , Biotina/química , Nanopartículas de Magnetita/química , Estreptavidina/química , Fosfatasa Alcalina/metabolismo , Glicerofosfolípidos/química , Ácido Oléico/química , Tamaño de la Partícula , Polietilenglicoles/química , Unión ProteicaRESUMEN
The use of iron oxide nanoparticles (IONPs) in biomedical research is steadily increasing, leading to the rapid development of novel IONP types and an increased exposure of cultured cells to a wide variety of IONPs. Due to the large variation in incubation conditions, IONP characteristics, and cell types studied, it is still unclear whether IONPs are generally safe or should be used with caution. During the past years, several contradictory observations have been reported, which highlight the great need for a more thorough understanding of cell-IONP interactions. To improve our knowledge in this field, there is a great need for standardized protocols and toxicity assays, that would allow to directly compare the cytotoxic potential of any IONP type with previously screened particles. Here, several approaches are described that allow to rapidly but thoroughly address several parameters which are of great impact for IONP-induced toxicity. These assays focus on acute cytotoxicity, induction of reactive oxygen species, measuring the amount of cell-associated iron, assessing cell morphology, cell proliferation, cell functionality, and possible pH-induced or intracellular IONP degradation. Together, these assays may form the basis for any detailed study on IONP cytotoxicity.
Asunto(s)
Compuestos Férricos/toxicidad , Nanopartículas del Metal/toxicidad , Animales , Polaridad Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Forma de la Célula/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Evaluación Preclínica de Medicamentos/métodos , Pruebas de Enzimas , Compuestos Férricos/metabolismo , Humanos , Concentración de Iones de Hidrógeno , L-Lactato Deshidrogenasa/química , L-Lactato Deshidrogenasa/metabolismo , Ratones , Microscopía Fluorescente , Neuritas/efectos de los fármacos , Células PC12 , Cultivo Primario de Células , Ratas , Especies Reactivas de Oxígeno/metabolismo , Coloración y EtiquetadoRESUMEN
The range of different types of nanoparticles and their biomedical applications is rapidly growing, creating a need to thoroughly examine the effects these particles have on biological entities. One of the most commonly used nanoparticle types is iron oxide nanoparticles, which can be used as MRI contrast agents. The main research topic is the in vitro labeling of cells with iron oxide nanoparticles to render the cells detectable for MRI upon in vivo transplantation. For the correct evaluation of cell function and behavior in vivo, any effects of the nanoparticles on the cells must be completely ruled out. The present work provides a technical note where a detailed overview is given of several assays that could be useful to determine nanoparticle toxicity. The assays described focus on (i) nanoparticle internalization, (ii) immediate cell toxicity, (iii) cell proliferation, (iv) cell morphology, (v) cell functionality and (vi) cell physiology. Potential pitfalls, appropriate controls and advantages/disadvantages of the different assays are given. The main focus of this work is to provide a detailed guide to help other researchers in the field interested in setting up nanoparticle-toxicity studies.
Asunto(s)
Compuestos Férricos/química , Nanopartículas/toxicidad , Pruebas de Toxicidad/métodos , Cationes , Muerte Celular/efectos de los fármacos , Liposomas , Magnetismo , Nanopartículas/químicaRESUMEN
The use of contrast material to stimulate magnetic resonance imaging (MRI) of migrating cells has become an important area of research. In the present study, cationic magnetoliposomes (MLs) were used to magnetically label human blood outgrowth endothelial cells (BOECs) and follow their homing by magnetic resonance imaging (MRI). The biodistribution and functional integration capacity of BOECs, which have shown extensive promise as gene delivery vehicles, have thus far only rarely been investigated. MLs were avidly internalized by BOECs giving clear MRI contrast in phantom studies and the magnetic labeling did not affect cell proliferation, viability, morphology or homeostasis and elicited only minor reactive oxygen species levels. Intravenous injection of labeled BOECs was compared with injection of free MLs and unlabeled BOECs, resulting in homing of BOECs toward the liver and spleen, which was confirmed by histology. The MLs used offer great potential for cellular tracking studies by MRI when low levels of widely distributed cells are present. In particular, the use of these MLs will allow to evaluate the efficacy of new methods to enhance BOEC homing and integration to optimize their use as efficient vehicles for gene therapy.
Asunto(s)
Medios de Contraste/metabolismo , Células Endoteliales/metabolismo , Liposomas/metabolismo , Imagen por Resonancia Magnética/métodos , Análisis de Varianza , Animales , Cationes/química , Cationes/metabolismo , Adhesión Celular , Movimiento Celular , Proliferación Celular , Supervivencia Celular , Medios de Contraste/química , Células Endoteliales/citología , Femenino , Técnicas de Transferencia de Gen , Humanos , Liposomas/química , Magnetismo , Ratones , Ratones Endogámicos NOD , Ratones SCID , Especies Reactivas de Oxígeno/análisis , Distribución TisularRESUMEN
MR-labeling of endogenous neural progenitor cells (NPCs) to follow up cellular migration with in vivo magnetic resonance imaging (MRI) is a very promising tool in the rapidly growing field of cellular imaging. To date, most of the in situ labeling work has been performed using micron-sized iron oxide particles. In this work magnetoliposomes (MLs), i.e. ultrasmall superparamagnetic iron oxide cores (USPIOs), each individually coated by a phospholipid bilayer, were used as the MR contrast agent. One of the main advantages of MLs is that the phospholipid bilayer allows easy modification of the surface, which creates the opportunity to construct a wide range of MLs optimized for specific biomedical applications. We have investigated the ability of MLs to label endogenous NPCs after direct injection into the adult mouse brain. Whereas MRI revealed contrast relocation towards the olfactory bulb, our data strongly imply that this relocation is independent of the migration of endogenous NPCs but represents background migration of MLs along a white matter tract. Our findings suggest that the small size of USPIOs/MLs intrinsically limits their potential for in situ labeling of NPCs.
Asunto(s)
Rastreo Celular/métodos , Medios de Contraste/farmacocinética , Óxido Ferrosoférrico/farmacocinética , Liposomas/farmacocinética , Movimiento/fisiología , Células-Madre Neurales/diagnóstico por imagen , Células-Madre Neurales/fisiología , Células Madre Adultas/citología , Células Madre Adultas/metabolismo , Células Madre Adultas/fisiología , Animales , Movimiento Celular/fisiología , Rastreo Celular/normas , Reacciones Falso Positivas , Óxido Ferrosoférrico/química , Hibridación in Situ , Liposomas/administración & dosificación , Imagen por Resonancia Magnética/métodos , Imagen por Resonancia Magnética/normas , Masculino , Ratones , Ratones Endogámicos C57BL , Células-Madre Neurales/citología , Células-Madre Neurales/metabolismo , Tamaño de la Partícula , Radiografía , Coloración y Etiquetado/métodosRESUMEN
The in vitro labelling of cultured cells with iron oxide nanoparticles (NPs) is a frequent practice in biomedical research. To date, the potential cytotoxicity of these particles remains an issue of debate. In the present study, 4 different NP types (dextran-coated Endorem, carboxydextran-coated Resovist, lipid-coated magnetoliposomes (MLs) and citrate-coated very small iron oxide particles (VSOP)) are tested on a variety of cell types, being C17.2 neural progenitor cells, PC12 rat pheochromocytoma cells and human blood outgrowth endothelial cells. Using different NP concentrations, the effect of the NPs on cell morphology, cytoskeleton, proliferation, reactive oxygen species, functionality, viability and cellular homeostasis is investigated. Through a systematic study, the safe concentrations for every particle type are determined, showing that MLs can lead up to 67.37 ± 5.98 pg Fe/cell whereas VSOP are the most toxic particles and only reach 18.65 ± 2.07 pg Fe/cell. Using these concentrations, it is shown that for MRI up to 500 cells/µl labelled with VSOP are required to efficiently visualize in an agar phantom in contrast to only 50 cells/µl for MLs and 200 cells/µl for Endorem and Resovist. These results highlight the importance of in-depth cytotoxic evaluation of cell labelling studies as at non-toxic concentrations, some particles appear to be less suitable for the MR visualization of labelled cells.
Asunto(s)
Muerte Celular/efectos de los fármacos , Compuestos Férricos/toxicidad , Nanopartículas/toxicidad , Coloración y Etiquetado/métodos , Animales , Ciclo Celular/efectos de los fármacos , Movimiento Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Fenómenos Químicos/efectos de los fármacos , Medios de Contraste/farmacología , Citoesqueleto/efectos de los fármacos , Citoesqueleto/metabolismo , Endocitosis/efectos de los fármacos , Adhesiones Focales/efectos de los fármacos , Adhesiones Focales/metabolismo , Homeostasis/efectos de los fármacos , Humanos , Espacio Intracelular/efectos de los fármacos , Espacio Intracelular/metabolismo , Hierro/metabolismo , Imagen por Resonancia Magnética , Células PC12 , Ratas , Especies Reactivas de Oxígeno/metabolismoRESUMEN
The in vitro labeling of cultured cells with nanomaterials is a frequent practice but the efficiency, specificity and cytotoxicity of labeling specific cell types using targeted nanoparticles has only rarely been investigated. In the present work, functionalized anionic lipid-coated iron oxide cores (magnetoliposomes (MLs)) bearing galactose moieties were used for the specific labeling of asialoglycoprotein receptor 1 (ASGPR-1)-expressing HepG2 cells. The optimal number of galactose moieties per particle (± 26) was determined and uptake efficiency was compared with galactose-lacking anionic and cationic MLs. Using a blocking assay with free galactose, electron microscopy and co-cultures of HepG2 and non-ASGPR-1 expressing C17.2 cells, the specificity of the particles for the ASGPR-1 receptor was demonstrated. The intracellular localization of the galactose-bearing MLs was further verified by confocal microscopy. The non-toxic ML concentration was determined to be 400 µg Fe/ml. Finally, the use of these MLs for visualization of labelled cells by magnetic resonance imaging (MRI) was demonstrated. The data show a high uptake and specificity of the galactose-bearing MLs, whereas the cationic MLs remain primarily surface-associated. Thus, targeted MLs offer a successful alternative for cell labeling when cationic particles fail to be efficiently internalized.
Asunto(s)
Compuestos Férricos/química , Liposomas/química , Nanopartículas/química , Coloración y Etiquetado/métodos , Animales , Calcio/metabolismo , Carcinoma Hepatocelular , Línea Celular , Proliferación Celular , Supervivencia Celular , Compuestos Férricos/metabolismo , Células Hep G2 , Humanos , Ratones , Especies Reactivas de Oxígeno/metabolismo , Transferrina/metabolismoRESUMEN
Among the wide variety in iron oxide nanoparticles which are routinely used as magnetic resonance imaging (MRI) contrast agents, magnetoliposomes (MLs) take up a special place. In the present work, the two main types (large and small MLs) are defined and their specific features are commented. For both types of MLs, the flexibility of the lipid coating allows for efficient functionalization, enabling bimodal imaging (e.g., MRI and fluorescence) or the use of MLs as theranostics. These features are especially true for large MLs, where several magnetite cores are encapsulated within a single large liposome, which were found to be highly efficient theranostic agents. By carefully fine-tuning the number of magnetite cores and attaching Gd(3+) -complexes onto the liposomal surface, the large MLs can be efficiently optimized for dynamic MRI. A special type of MLs, biogenic MLs, can also be efficiently used in this regard, with potential applications in cancer treatment and imaging. Small MLs, where the lipid bilayer is immediately attached onto a solid magnetite core, give a very high r2 /r1 ratio. The flexibility of the lipid bilayer allows the incorporation of poly(ethylene glycol)-lipid conjugates to increase blood circulation times and be used as bone marrow contrast agents. Cationic lipids can also be incorporated, leading to high cell uptake and associated strong contrast generation in MRI of implanted cells. Unique for these small MLs is the high resistance the particles exhibit against intracellular degradation compared with dextran- or citrate-coated particles. Additionally, intracellular clustering of the iron oxide cores enhances negative contrast generation and enables longer tracking of labeled cells in time.
Asunto(s)
Medios de Contraste , Liposomas , Imagen por Resonancia Magnética/métodos , Nanopartículas de Magnetita , Animales , Química Encefálica , Línea Celular , Medios de Contraste/administración & dosificación , Humanos , Liposomas/administración & dosificación , Nanopartículas de Magnetita/administración & dosificación , Células Madre/citología , Células Madre/metabolismoRESUMEN
The in vitro labeling of stem or therapeutic cells with engineered nanoparticles with the aim of transplanting these cells into live animals and, for example, noninvasively monitoring their migration, is a hot topic in nanomedicine research. It is of crucial importance that cell-nanoparticle interactions are studied in depth in order to exclude any negative effects of the cell labeling procedure. To date, many disparate results can be found in the literature regarding nanoparticle toxicity due to the great versatility of different parameters investigated. In the present work, an overview is presented of different types of nanomaterials, focusing mostly on iron oxide nanoparticles, developed for biomedical research. The difficulties in assessing nanoparticle-mediated toxicity are discussed, an overview of some of the problems encountered using commercial (dextran-coated) iron oxide nanoparticles is presented, several key parameters are highlighted and novel methods suggested--emphasizing the importance of intracellular nanoparticle degradation and linking toxicity data to functional (i.e., cell-associated) nanoparticle levels, which could help to advance any progress in this highly important research topic.
Asunto(s)
Compuestos Férricos/toxicidad , Nanopartículas/toxicidad , Animales , Supervivencia Celular , Trasplante de Células/métodos , Células Cultivadas/patología , Humanos , Magnetismo , Nanocápsulas/estadística & datos numéricos , Nanomedicina/tendencias , Nanosferas/estadística & datos numéricos , Neuritas/metabolismo , Células PC12/citología , Células PC12/metabolismo , RatasRESUMEN
Iron oxide nanoparticles (NPs) are frequently employed in biomedical research as magnetic resonance (MR) contrast agents where high intracellular levels are required to clearly depict signal alterations. To date, the toxicity and applicability of these particles have not been completely unraveled. Here, we show that endosomal localization of different iron oxide particles results in their degradation and in reduced MR contrast, the rate of which is governed mainly by the stability of the coating. The release of ferric iron generates reactive species, which greatly affect cell functionality. Lipid-coated NPs display the highest stability and furthermore exhibit intracellular clustering, which significantly enhances their MR properties and intracellular persistence. These findings are of considerable importance because, depending on the nature of the coating, particles can be rapidly degraded, thus completely annihilating their MR contrast to levels not detectable when compared to controls and greatly impeding cell functionality, thereby hindering their application in functional in vivo studies.
Asunto(s)
Medios de Contraste/química , Compuestos Férricos/química , Nanopartículas del Metal/química , Medios de Contraste/análisis , Endocitosis , Compuestos Férricos/análisis , Concentración de Iones de Hidrógeno , Espectroscopía de Resonancia Magnética/instrumentación , Espectroscopía de Resonancia Magnética/métodos , Nanopartículas del Metal/análisisRESUMEN
Iron oxide nanoparticle internalization exerts detrimental effects on cell physiology for a variety of particles, but little is known about the mechanism involved. The effects of high intracellular levels of four types of iron oxide particles (Resovist, Endorem, very small organic particles, and magnetoliposomes (MLs)) on the viability and physiology of murine C17.2 neural progenitor cells and human blood outgrowth endothelial cells are reported. The particles diminish cellular proliferation and affect the actin cytoskeleton and microtubule network architectures as well as focal adhesion formation and maturation. The extent of the effects correlates with the intracellular concentration (= iron mass) of the particles, with the biggest effects for Resovist and MLs at the highest concentration (1000 microg Fe mL(-1)). Similarly, the expression of focal adhesion kinase (FAK) and the amount of activated kinase (pY397-FAK) are affected. The data suggest that high levels of perinuclear localized iron oxide nanoparticles diminish the efficiency of protein expression and sterically hinder the mature actin fibers, and could have detrimental effects on cell migration and differentiation.
Asunto(s)
Citoesqueleto/efectos de los fármacos , Citoesqueleto/metabolismo , Compuestos Férricos/farmacología , Proteína-Tirosina Quinasas de Adhesión Focal/metabolismo , Espacio Intracelular/metabolismo , Nanopartículas del Metal/química , Transducción de Señal/efectos de los fármacos , Actinas/metabolismo , Animales , Transporte Biológico/efectos de los fármacos , Movimiento Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Activación Enzimática/efectos de los fármacos , Adhesiones Focales/efectos de los fármacos , Adhesiones Focales/enzimología , Humanos , Espacio Intracelular/efectos de los fármacos , Ratones , Microtúbulos/efectos de los fármacos , Microtúbulos/metabolismo , Modelos Biológicos , Tamaño de la Partícula , Coloración y Etiquetado , Propiedades de Superficie/efectos de los fármacosRESUMEN
Cholecystokinin, produced in the proximal small intestine, is a short acting satiating peptide hormone. CCK-10, before and after mono-iodination, was previously coupled to 10kDa polyethylene glycol (PEG). The formed conjugates PEG10kDa-CCK-10 and PEG10kDa-[(127)I]-CCK-10 show after i.p. administration to rats a sustained food intake reduction during 8h in comparison to 2h for free CCK-10. The present study examined the blood pharmacokinetics of this pharmacological interesting molecule by means of PEG10kDa-[(123)I]-CCK-10 following intravenous, intraperitoneal, intramuscular and nasal administration and the biodistribution after i.p. administration. HPLC analysis with radiometric detection allowed the differentiation between inorganic iodide and the intact tracer in blood. Blood kinetics after i.v. injection was fitted to a bi-exponential with a distribution half-life of 15 min and with an elimination half-life of 8 hours for intact PEG10kDa-[(123)I]-CCK-10. The biodistribution studies showed a higher accumulation of the tracer for all administration routes in organs expressing CCK receptors localized in the gastrointestinal tract such as pancreas, duodenum and small intestine. No indication of blood brain barrier crossing for the conjugate could be observed independently of the administration route. Main clearance was via the urinary pathway.
Asunto(s)
Colecistoquinina/sangre , Portadores de Fármacos/farmacocinética , Radioisótopos de Yodo/sangre , Fragmentos de Péptidos/sangre , Polietilenglicoles/farmacocinética , Animales , Colecistoquinina/administración & dosificación , Colecistoquinina/orina , Vías de Administración de Medicamentos , Portadores de Fármacos/administración & dosificación , Portadores de Fármacos/síntesis química , Portadores de Fármacos/química , Semivida , Radioisótopos de Yodo/orina , Masculino , Fragmentos de Péptidos/administración & dosificación , Fragmentos de Péptidos/orina , Polietilenglicoles/administración & dosificación , Polietilenglicoles/química , Ratas , Ratas Wistar , Distribución TisularRESUMEN
Magnetoliposomes (MLs) consist of nanosized, magnetisable iron oxide cores (magnetite, Fe(3)O(4)) which are individually enveloped by a bilayer of phospholipid molecules. To generate these structures, the so-called water-compatible magnetic fluid is first synthesized by co-precipitation of Fe(2+) and Fe(3+) salts with ammonia and the resulting cores are subsequently stabilized with lauric acid molecules. Incubation and dialysis of this suspension with an excess of sonicated, small unilamellar vesicles, ultimately, results in phospholipid-Fe(3)O(4) complexes which can be readily captured from the solution by high-gradient magnetophoresis (HGM), reaching very high yields. Examination of the architecture of the phospholipid coat reveals the presence of a typical bilayered phospholipid arrangement. Cationic MLs are then produced by confronting MLs built up of zwitterionic phospholipids with vesicles containing the relevant cationic lipid, followed by fractionation of the mixture in a second HGM separation cycle. Data, published earlier by our group (Soenen et al., ChemBioChem 8:2067-2077, 2007) prove that these constructs are unequivocal biocompatible imaging agents resulting in a highly efficient labeling of biological cells.
Asunto(s)
Cationes/química , Óxido Ferrosoférrico/química , Liposomas/química , Magnetismo/métodos , Diseño de Equipo , Magnetismo/instrumentación , Microscopía Electrónica de Transmisión , Fosfolípidos/químicaRESUMEN
Iron oxide nanoparticles are the most widely used T(2)/T(2)* contrast agents and for biomedical research purposes, one of the main applications is the in vitro labeling of stem or therapeutic cells, allowing them to be subsequently tracked in vivo upon transplantation. To allow this, the nanoparticles used should not show any sign of cytotoxicity and not affect cellular physiology as this could impede normal cell functionality in vivo or lead to undesired side-effects. Assessing the biocompatibility of the nanoparticles has proven to be quite a difficult task. In the present work, a small overview of commonly used assays is presented in order to assess several aspects, such as cell viability, induction of reactive oxygen species, nanoparticle uptake, cellular morphology, cellular proliferation, actin cytoskeleton architecture and differentiation of stem cells. The main focus is on comparing the advantages and disadvantages of the different assays, highlighting several common problems and presenting possible solutions to these problems as well as pointing out the high importance of the relationship between intracellular nanoparticle concentration and cytotoxicity.
Asunto(s)
Compuestos Férricos/toxicidad , Liposomas/farmacología , Magnetismo/métodos , Nanopartículas/química , Nanopartículas/toxicidad , Animales , Cationes , Muerte Celular/efectos de los fármacos , Compuestos Férricos/efectos adversos , Humanos , Nanopartículas/efectos adversosRESUMEN
Magnetoliposomes (MLs), built up of ultrasmall iron oxide cores each individually surrounded by a lipid bilayer, have emerged as highly biocompatible nanoparticles and promising tools in many biomedical applications. To improve cell uptake, cationic amphiphiles are inserted into the ML coat, but this often induces cytotoxic effects. In the present work, we synthesized and tested a cationic peptide-lipid conjugate (dipalmitoylphosphatidylethanolamine-succinyl-tetralysine [DPPE-succ-(Lys)4]) which is entirely composed of biodegradable moieties and specifically designed to exert minimal cytotoxic effects. Uptake studies with both murine 3T3 fibroblasts and C17.2 neural progenitor cells shows 95.63 +/- 5.83 pg Fe and 87.46 +/- 5.62 pg Fe per cell after 24 h, respectively, for 16.66% DPPE-succ-(Lys)4-containing MLs, with no effect on cell viability. However, these high intracellular nanoparticle concentrations transiently affect actin cytoskeleton architecture, formation of focal adhesion complexes and cell proliferation, returning to control levels after approximately 7 days post ML-incubation in both cell types. This study points out the great need for thorough characterization of cell-nanoparticle interactions as subtle time-dependent effects are hard to monitor and commonly used viability and functionality assays are not sufficient to address the broad spectrum of possible interferences of the nanoparticle with normal cell functioning.